CLINICAL_TRIALS
trial_result
· 2020-01-13
Clinical Trial Update: Examination of the Anti-inflammatory and Insulin Sensitizing Properties of Doxycycline in Humans [Phase 4]
Summary
Phase 4 clinical trial update examining doxycycline for anti-inflammatory and insulin-sensitizing effects in humans with type 2 diabetes and obesity.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Diego | Conditions: Type 2 Diabetes, Obesity | Phase 4 | Status: COMPLETED | Results posted: 2020-01-13